Abstract
Venetoclax with Low-Dose Cytarabine Induces Rapid, Deep, and Durable Responses in Previously Untreated Older Adults with AML Ineligible for Intensive Chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have